top of page
Chemotherapy Protocols
MYELOMA CLINICAL TRIALS
Multiple Myeloma Patient Education
Home
Trials
MCT Tags
NDMM Trials
RRMM Trials
MGUS/SMM Trials
Phase 3 Trials
Phase 2 Trials
Phase 1/2 Trials
Phase 1 Trials
CART Trials
FAQ
What is Myeloma?
What is a Clinical Trial?
Immunotherapy / CART
Labs
Infection Prevention
Myeloma Genomics
Transplant
Precursor Conditions
MRD
Patient Symposium
Miscellaneous
Drugs
Treatment Agents
FDA
Centers
Events
About us
About us
Contact
All Posts
More
Use tab to navigate through the menu items.
FAQs: Minimal Residual Disease (MRD)
Dec 21, 2021
Patient Education: FAQ
Multiple Myeloma Research Foundation - MMRF - Minimal Residual Disease (MRD)
Multiple Myeloma Research Foundation - MMRF - Minimal Residual Disease (MRD) | High Impact Topic HIT MRD (Minimal residual disease):...
Dec 1, 2021
Patient Education: FAQ
clonoSEQ: Adaptive Biotechnologies - What is Minimal residual disease (MRD)?
What is Minimal residual disease (MRD)? MRD (Minimal Residual Disease) is a small number of malignant plasma cells that remain in the...
bottom of page
